Daktari Diagnostics develops simple, accurate, and affordable products that address the most pressing challenges in global health. We are committed to delivering critical diagnostic test results to clinicians and patients across the globe.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/13/13 | $7,000,000 | |||
| 03/03/15 | $15,500,000 | Series D |
Eastern Capital Merck Global Health Innovation Fund Norwich Ventures Partners Innovation Fund | undisclosed |
